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Abstract 
A series of bifunctional phosphine oxides have been prepared and evaluated as catalysts for the 
trichlorosilane mediated asymmetric hydrosilylation of ketimines. bis-Phosphine oxides, 
hydroxy-phosphine oxides, and biaryl phosphine oxides all demonstrated good catalytic 
activity, but poor to moderate enantioselectivity. A bis-P-chiral phosphine oxide displayed the 





Non-symmetrically substituted phosphorus compounds are commonplace throughout organic 
chemistry both as chiral ligands and more recently as organocatalysts.[1–5] Despite their 
prevalence, the majority of examples reported utilise a P-chiral phosphine as the catalytic 
moiety, with very few reports of the application of the analogous P-chiral phosphine oxides. 
The earliest report of the use of a P-chiral phosphine oxide detailed the application as a ligand 
for asymmetric transfer hydrogenation of ketones,[6] and subsequent studies have shown 
applicability in a number of synthetic applications, including Diels-Alder reactions,[7] 
enantioselective allylation of -hydrazono esters,[8] desymmetrisation of diaryl meso-
epoxides,[9] reductive aldol condensations,[10] and reductive cyclisation of N-acylated-β-
amino enones.[11] The latter two transformations make use of trichlorosilane as a reductant, a 
reagent known for susceptibility for activation by Lewis base catalysts, a majority of which are 
amide based.[12] However, Sun has used S-chiral sulfoxides to affect asymmetric 
hydrosilylation of ketimines,[13] further developing initial disclosures with a second 
generation bis-S-chiral sulfoxide that delivered consistently higher reactivity and 
selectivity.[14] Sun’s group also went on to develop an organocatalyst with both carbon and 
sulfur stereogenic centres to promote the enantioselective hydrosilylation of 1,4-
benzooxazines.[15]  
Work from our laboratories has developed imidazole derived organocatalysts for the 
asymmetric hydrosilylation of ketimines that operate very effectively at exceptionally low 
catalyst loading,[16] and proposed a dual activation model for this behaviour based on catalysts 
containing both Lewis basic and Brønsted acidic functionality.[17] We have also explored the 
use of P-chiral phosphine oxides as catalysts for this reaction.[18] Although these species 
displayed potent catalytic activity, they struggled to deliver enantioselectivities of greater than 
28% ee. Notably, these phosphine oxides displayed a negative non-linear effect, which is in-
line with that observed with S-chiral catalysts developed by Sun. In this work we describe 
efforts to bring together these key design elements; dual activation to provide a catalyst which 
displays no non-linear effects. 
Results and Discussion 
Initial studies sought to accrue data to validate the proposed dual activation hypothesis. A series 
of potential catalysts were targeted bearing phosphine oxide and alcohol functional groups with 
different length spacers between these. Achiral diphenyl bis-phosphine oxide catalysts 1–7 
were synthesised with chain lengths varying from two to nine carbon atoms, following 
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established literature precedent.[19] Thus, the appropriate alkyldihalide was treated with 
triphenylphosphine to form the bis-phosphonium salt, followed by reaction with concentrated 
sodium hydroxide to afford the desired catalysts in excellent yield (Scheme 1). The hydroxy-
phosphine oxides 8–10 were prepared adopting a similar route used for the bis-phosphine 
oxides, but instead starting with the appropriate halohydrin or halo-acetate (Scheme 1).  
 
Scheme 1. Synthesis of bis-phosphine oxides 1-7 and hydroxy-phosphine oxides 8-10. 
 
The prepared catalysts 1–10 were then trialled in the reduction of a benchmark ketimine 
substrate 11 to the PMP-amine 12 under standard previously employed reaction conditions 
(Scheme 2 and Table 1). For the bis-phosphine oxides 1–7, there appears to be an optimum 
chain length of six-carbon atoms that delivers the highest conversion (Table 1, compare entries 
1–7). The smaller subset of hydroxy-phosphine oxides provided fairly consistent conversion, 
with the highest observed with the five-carbon linker (Table 1, entries 8-10). 
 
Scheme 2. Reduction of PMP-ketimine 11 using the achiral phosphine oxide catalysts. 
 
Table 1. Conversion of ketamine 11 to amine 12 according to Scheme 2.a 

































a All reactions performed according to Scheme 2 at a 1 mmol scale using 1 mL of solvent; b determined by 
comparison of appropriate integrals of starting material and product in the 1H NMR spectrum of the unpurified 
reaction mixture. Data refers to the average of two reactions. 
 
Next, a series of easily accessible enantiopure phosphine oxides were targeted, two being based 
on a conformationally flexible sidechain 13 and 14, and the others on a more rigid binaphthyl 
framework, 15 and 16. Oxidation of the commercially available enantiopure phosphines with 
hydrogen peroxide gave the bis-phosphine oxides 13–16 in excellent yield following known 
literature precedent.[20,21] 
 
Scheme 3. Synthesis of chiral bis-phosphine oxides 13–16. 
A series of biaryl catalysts were also synthesised incorporating a Brønsted acidic hydroxyl 
group also based upon a binaphthyl framework. Following known literature precedent, the 
mono ortho-tolyl and para-methoxy catalysts 21 and 22 were both successfully synthesised 





Scheme 4. Synthesis of biaryl-hydroxy BINOL catalysts 21 and 22. 
 
Analysis of these catalysts under the standard reduction conditions (Scheme 2) demonstrated 
that all reduced the PMP-ketimine 11 but with varying degrees of efficiency. The catalyst 
bearing a two carbon linker was more effective than the achiral counterpart (compare Table 1, 
entry 1 verses Table 2, entry 1) which may be due to the chiral version exhibiting gauche 
interactions of the methyl groups when the phosphine oxides are anti-periplanar, preferring a 
syn-periplanar arrangement that promotes a dual activation mechanism. This effect is also 
mirrored in the catalyst with stereogenic phosphorus centres; with no methyl groups on the 
backbone, the reactivity drops (Table 2, entries 1 & 2). Although only small, a better 
enantioselectivity is observed with stereogenic phosphorus centres rather than carbon centered 
ones on the backbone. In contrast, (S)-BINAPO derived catalysts 21 and 22 both performed 
excellently as catalysts, but delivered very similar enantioselectivities depending on the nature 
of the aryl phosphine oxides used (Table 2, entries 3 & 4). In contrast the hydroxy-BINOL 
phosphine oxides where considerably less reactive, with no significant improvement in 
enantioselectivity (Table 2, entries 5 & 6). 
 
 
Table 2. Conversion of ketamine 2 to amine 1 according to Scheme 2.a 





















a All reactions performed according to Scheme 2 at a 1 mmol scale using 1 mL of solvent; b determined by 
comparison of appropriate integrals of starting material and product in the 1H NMR spectrum of the unpurified 
reaction mixture. Data refers to the average of two reactions; c enantiomeric excess determined by chiral phase 
HPLC analysis. 
 
Further hydroxy-phosphine oxide catalysts were prepared based on a more conformationally 
mobile framework bearing a stereogenic alcohol centre. Thus, the commercially available 
chloro-nitrile 23 was treated with phenylmagnesium bromide to afford the chloro-ketone 24 in 
excellent yield (Scheme 5).[23] This was reduced using an oxazaborolidine derived from (1R, 
2S)-amino indanol and trimethylborate at 0 °C,[24] and the resulting alcohol 25 protected as a 
TBS ether 26. Formation of the phosphonium salt and subsequent oxidation to the phosphine 
oxide using 3 M NaOH afforded the TBS protected catalyst that was deprotected with TBAF 
to form the target molecule 27 in six steps. In order to determine the enantioselectivity of 
catalyst 27, a racemic version of the catalyst was synthesised in analogous fashion using the 
racemic alcohol derived from the sodium borohydride reduction of chloro-ketone 24. Analysis 
of the enantioselectivity of the catalyst by chiral HPLC analysis showed a 91% ee, which was 
sufficient to enable its use. A shorter 3-carbon analogue 29 was also synthesised through the 
ring opening of an enantiomerically pure epoxide with a lithium phosphinate derived from 





Scheme 5. Synthesis of hydroxy-phosphine oxide catalysts 27 and 29. 
 
Table 3. Reduction of the PMP-ketimine 11 using chiral hydroxy-phosphine oxide catalysts 27 and 29a 







a All reactions performed according to Scheme 1 at a 1 mmol scale using 1 mL of solvent; b determined by 
comparison of appropriate integrals of starting material and product in the 1H NMR spectrum of the unpurified 
reaction mixture. Data refers to the average of two reactions; c enantiomeric excess determined by chiral phase 
HPLC analysis; d Catalyst used was 91% ee. 
 
Screening of the phosphine oxides 27 and 29 under benchmark conditions (Scheme 2) 
demonstrated very similar conversion to the PMP-amine 12 after 4 hours to those obtained with 
the achiral linear variant of the catalysts. However, in both cases, the amine 12 was obtained 
in a 10% ee in both cases. This indicates that a stereogenic centre located at these positions on 
the carbon chain has only a small effect on the overall enantioselectivity.  
As already noted, use of P-chiral phosphine oxides demonstrated negative [ML2] non-linear 
effects similar to observed by Sun and co-workerswith an analogous S-chiral sulfoxide. Thus, 
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a P-chiral phosphine oxide that delivered the highest enantioselectivity was selected and a bis-
phosphine oxide prepared with an appropriate 6-carbon linker that was shown to be the most 
effective chain length in earlier experiments (Table 1, entry 5). Controlled addition of the P-
chiral oxazolidinone 30 to a solution of but-3-enylmagnesium bromide employing previously 
developed methodology for the synthesis of P-chiral phosphine oxides gave the desired P-
chiral phosphine oxide 31 as a single enantiomer (>99% ee as determined by chiral HPLC 
analysis).[26] Treatment of this with 10 mol% of Grubbs-Hoveyda second generation catalyst 
followed by immediate hydrogenation afforded the desired catalyst 32 in good yield over two 
steps (Scheme 6) 
 
Scheme 6. Synthesis of P-chiral bis-phosphine oxide catalyst 32. a Reaction performed according to Scheme 1 
at a 1 mmol scale using 1 mL of solvent. 
 
The bis-phosphine oxide catalyst 32 was evaluated under the standard reduction conditions 
(Scheme 2), undergoing 88% conversion to the N-PMP amine 12. Analysis of the 
enantioselectivity of the reduction showed a 60% ee and is consistent with the hypothesis that 
two phosphine oxide moieties were required to enable high enantiocontrol. To further confirm 
this, a non-linear relationship study was again undertaken on catalyst 32 (Fig. 1), where 
scalemic mixtures of the catalyst 32 were accessed by mixing the opposing enantiomer of the 
bis-phosphine oxide, prepared in analogous fashion using the N-phosphinoyl oxazolidinone 
derived from (R)-valine. The observation of a direct linear relationship between the 
enantioselectivity of the catalyst and the enantioselectivity of the resultant N-PMP amine 12 
confirmed that the reaction now proceeded through a pathway whereby only a single molecule 
of the catalyst 32 was present in the transition state, and confirms a need to have stereogenic 




Figure 1. Probing non-linear activity of catalyst 32 using reaction conditions according to Scheme 2. 
In the recently disclosed dual activation model with the organocatalyst derived from imidazole, 
trichlorosilane is coordinated to the Lewis basic amide and the hydroxyl group, whilst the 
protonated imidazole activates the imine substrate. One can propose a similar model for the 
bis-phosphine oxide 32 where each terminus can act as a Lewis base or a Bronsted acid. The 
same model overlays well with a catalyst system developed by Sun and co-workers based on 
chiral sulfoxides that displays similar non-linear effects. 
 
 
Figure 2. Dual activation models for the imidazole, phosphine oxide, and sulfoxide catalysts. 
Conclusion 
P-Chiral phosphine oxides offer potential for acting as effective catalysts for the asymmetric 
reduction of ketimines. Symmetric variants offer good reactivity and selectivity but 
refinements are needed in order to improve the levels of selectivity further. Potential exists for 





























General procedure A for the preparation of the achiral bis-phosphine oxide catalysts 
The dibromoalkane (5 mmol) and triphenyl phosphine (2.60 g, 10 mmol) were dissolved in 
MeCN (20 mL) and the solution heated to reflux for 18 h. Upon cooling to room temperature 
the solvent was removed in vacuo to afford the crude phosphonium salt. The phosphonium salt 
was redissolved in a solution of MeOH (10 mL) and aqueous 6 M KOH solution (10 mL) and 
heated at reflux for a further 24 h. The solvent was removed in vacuo to afford the crude bis-
phosphine oxide. Purification of the crude material occurred as described within the individual 
experimental details. 
1,2-bis(Diphenylphosphinyl)ethane 1[27] 
Prepared according to general procedure A from 1,2-dibromoethane (0.4 mL, 5 mmol). 
Recrystallisation of the crude compound from MeOH: EtOAc afforded the title compound as 
a white crystalline solid (2.02 g, 95%); m.p. 273–274 °C (lit.[27] 273–276 °C); δH (400 MHz, 
CDCl3) 2.51 (4 H, d, JP-H 1.8, 2 × CH2), 7.41–7.53 (12 H, m, ArCH), 7.66–7.73 (8 H, m, ArCH); 
δP (101 MHz, CDCl3) 32.5. All data is in accordance with that in the literature. 
1,3-bis(Diphenylphosphinyl)propane 2[27] 
Prepared according to general procedure A from 1,3-dibromopropane (0.5 mL, 5 mmol). 
Recrystallisation of the crude material from MeOH: EtOAc afforded the title compound as a 
white solid (1.61 g, 72%); m.p. 140–141 °C (lit.[27] 139–140 °C); δH (400 MHz, CDCl3) 1.92–
2.08 (2 H, m, CH2), 2.45–2.56 (4 H, m, 2 × CH2), 7.39–7.52 (12 H, m, ArCH), 7.65–7.72 (8 H, 
m, ArCH); δP (101 MHz, CDCl3) 32.2. All data is in accordance with the literature. 
1,4-bis(Diphenylphosphinyl)butane 3[27] 
Prepared according to general procedure A from 1,4-dibromobutane (0.6 mL, 5 mmol). 
Recrystallisation of the crude material from MeOH: EtOAc afforded the title compound as a 
white crystalline solid (1.81 g, 80%); m.p. 267–268 °C (lit.[27] 267–269 °C); δH (400 MHz, 
CDCl3) 1.67–1.79 (4 H, m, 2 × CH2), 2.21–2.28 (4 H, m, 2 × CH2), 7.42–7.53 (12 H, m, ArCH), 





Prepared according to general procedure A from 1,5-dibromopentane (0.7 mL, 5 mmol). 
Recrystallisation of the crude material from MeOH: EtOAc afforded the title compound as a 
white crystalline solid (1.64 g, 67%); m.p. 119–120 °C (lit.[29] 119–120 °C); δH (400 MHz, 
CDCl3) 1.55–1.69 (6 H, m, 3 × CH2), 2.15–2.26 (4 H, m, 2 × CH2), 7.44–7.48 (12 H, m, ArCH), 
7.66–7.74 (8 H, m, ArCH); δP (101 MHz, CDCl3) 32.2. All data is in accordance with the 
literature. 
1,6-bis(Diphenylphosphinyl)hexane 5[28] 
Prepared according to general procedure A from 1,6-dibromohexane (0.8 mL, 5 mmol). 
Recrystallisation of the crude material from MeOH : EtOAc afforded the title compound as a 
white crystalline solid (1.53 g, 64%); m.p. 196–197 °C (lit.[28] 196.9–197.2 °C); δH (400 MHz, 
CDCl3) 1.35–1.42 (4 H, m, 2 × CH2), 1.54–1.65 (4 H, m, 2 × CH2), 2.19–2.26 (4 H, m, 2 × 
CH2), 7.44–7.56 (12 H, m, ArCH), 7.69–7.76 (8 H, m, ArCH); δP (101 MHz, CDCl3) 32.1. All 
data is in accordance with that of the literature. 
1,7-bis(Diphenylphosphinyl)heptane 6[28] 
Prepared according to general procedure A from 1,7-dibromoheptane (0.9 mL, 5 mmol). 
Recrystallisation of the crude material from MeOH: EtOAc afforded the title compound as a 
white crystalline solid (2.01 g, 80%); m.p. 90–91 °C (lit.[28] 90–91 °C); δH (250 MHz, CDCl3) 
0.84–0.92 (2 H, m, CH2), 1.23–1.43 (4 H, m, 2 × CH2), 1.50–1.67 (4 H, m, 2 × CH2), 2.17–
2.30 (4 H, m, 2 × CH2), 7.42–7.58 (12 H, m, ArCH), 7.68–7.78 (8 H, m, ArCH); δP (101 MHz, 
CDCl3) 32.3. All data is in accordance with the literature. 
1,9-bis(Diphenylphosphinyl)nonane 7[30,31] 
Prepared according to general procedure A from 1,9-dibromononane (2.62 g, 5 mmol). 
Recrystallisation of the crude compound from MeOH: EtOAc afforded the title compound as 
a white crystalline solid (1.80 g, 70%); m.p. 123–125 °C (lit.[30] 123–125 °C); δH (250 MHz, 
CDCl3) 1.10–1.38 (10 H, m, 5 × CH2), 1.52–1.68 (4 H, m, 2 × CH2), 2.19–2.30 (4 H, m, 2 × 
CH2), 7.43–7.56 (12 H, m, ArCH), 7.70–7.78 (8 H, m, ArCH); δP (101 MHz, CDCl3) 32.4. All 
data is in accordance with the literature. 
General procedure B for the formation of the diphenylphosphine oxide moiety from the 
halogenated alcohol or ester 
The halogenated alcohol or ester (7 mmol) was added dropwise to a suspension of sodium 
iodide (1.00 g, 7 mmol) and triphenylphosphine (2.00 g, 7.0 mmol) in acetonitrile (20 cm³) and 
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the reaction mixture heated at reflux for 24 hours. The solution was cooled to room temperature 
and the solvent removed in vacuo to yield the phosphonium salt. The salt was dissolved in a 
30% aqueous solution of NaOH (20 cm³) and methanol (10 cm³) and heated at reflux for 12 
hours. The reaction mixture was poured into a saturated solution of ammonium chloride (20 
cm³) and the aqueous phase extracted with dichloromethane (3 × 30 cm³). The organic layers 
were combined, washed with brine (10 cm³) and dried over magnesium sulfate. Removal of the 
solvent in vacuo afforded the crude material. Purification of the crude material occurred as 
described in the individual experimental details. 
3-(Diphenylphosphinyl)-1-propanol 8[32] 
Prepared in accordance to general procedure B using 3-chloro-propan-1-ol (0.7 cm³, 7 mmol). 
Trituration of the crude material from diethyl ether (20 cm³) gave the title compound as a white 
crystalline solid (0.60 g, 24%); m.p. 95 °C (lit.[32] 95–96 °C); δH (400 MHz, CDCl3) 1.83–
1.93 (2 H, m, CH2), 2.42 (2 H, dt, J 11.5 7.3, PCH2), 3.69–3.72 (2 H, m, CH2OH), 4.23 (1 H, 
br s, OH), 7.45–7.55 (6 H, m, ArCH), 7.72–7.77 (4 H, m, ArCH); δP (101 MHz, CDCl3) 34.7. 
All data is in accordance with the literature. 
4-(Diphenylphosphinyl)butan-1-ol 9[33] 
Prepared according to general procedure B using 4-iodobutyl benzoate[33] (2.00 g, 7 mmol). 
Purification of the crude material by  flash column chromatography on silica gel using an eluent 
of 100% ethyl acetate afforded the title compound as a colourless oil (270 mg, 19%); δH (400 
MHz, CDCl3) 1.65–1.79 (4 H, m, CH2), 2.28–2.38 (2 H, m, CH2), 2.90 (1 H, br s, OH), 3.65 (2 
H, t, J 5.8, CH2OH), 7.28–7.55 (6 H, m, ArCH), 7.67–7.78 (4 H, m, ArCH); δP (101 MHz, 
CDCl3) 33.7. All data is in accordance with that of the literature.  
5-(Diphenylphosphinyl)pentan-1-ol 10[34] 
Prepared according to general procedure B using 5-bromopentan-1-ol (1.00 g, 7 mmol). 
Purification of the crude material by flash column chromatography on silica gel using an eluent 
of 100% ethyl acetate afforded the title compound as a colourless oil (700 mg, 39%); δH (400 
MHz, CDCl3) 1.43–1.75 (6 H, m, 3 × CH2), 1.95 (1 H, br s, OH), 2.21–2.34 (2 H, m, CH2), 
3.61 (2 H, t, J 6.3, CH2OH), 7.42–7.54 (6 H, m, ArCH), 7.70–7.78 (4 H, m, ArCH); δH (101 
MHz, CDCl3) 32.7. All data is in accordance with that of the literature. 
General procedure for the asymmetric reduction of the PMP-ketimine 11 
The PMP-ketimine 11 (225 mg, 1.00 mmol) and catalyst (0.1 mmol) were dissolved in CH2Cl2 
(1 cm³) and the solution cooled to 0 °C. Trichlorosilane (0.20 cm³, 2.0 mmol) was added 
dropwise and the reaction mixture stirred for 4 hours. The reaction solution was quenched 
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through addition of 1M aqueous HCl solution (1 cm³), diluted with CH2Cl2 (5 cm³) and basified 
with a 1M aqueous NaOH solution (10 cm³). The organic phase was separated, and the aqueous 
phase extracted with CH2Cl2 (3 × 5 cm³). The combined organics were washed with brine (10 
cm³), before being dried over MgSO4, filtered and concentrated in vacuo to yield the crude 
material. Purification of the crude product by flash column chromatography eluting on silica 
gel with 10% EtOAc / petroleum ether afforded the desired amine 12 as a golden yellow solid; 
m.p. 64 °C (lit.[16] 65 °C); δH (400 MHz, CDCl3) 1.52 (3H, d, J 6.7, CH3CHN), 3.80 (3H, s, 
OCH3), 3.83 (1H, bs, NH), 4.42 (1H, q, J 6.7, CH3CHN), 6.48 [2H, (AX)2, ArCH], 6.70 (2H, 
(AX)2, ArCH], 7.20 – 7.25 (5H, m, ArCH); HPLC tR = 7.9 min. (R isomer), 8.6 min. (S isomer) 
(Chiralpak AD, 95/5 hexane/propan-2-ol); All data is in accordance with the literature. 
(2R, 3R)-(+)- 2,3-bis(Diphenylphosphinyl)butane 13[35] 
(2R, 3R)-(+)-bis(Diphenylphosphino)butane (200 mg, 0.5 mmol) was dissolved in CH2Cl2 (10 
cm³) and the reaction solution cooled to 0 °C. Hydrogen peroxide (35 wt. %, 0.5 cm³) was 
added dropwise and the reaction mixture stirred for 18 hours. The solution was poured into 
water (10 cm³) and the organic phase separated. The aqueous layer was extracted with 
dichloromethane (3 × 10 cm³) and the organic phases combined, washed with a saturated 
aqueous solution of sodium sulfite (15 cm³) and dried over magnesium sulfate. Filtration, then 
removal of the solvent in vacuo afforded the title compound as a white crystalline solid that 
required no further purification (203 mg, 94%); m.p. 183 °C (lit.[35] 183–184 °C); []D25 +39.0 
(c 2.0 in CH2Cl2, lit.[35]
 +39.4 c 2.0 in CH2Cl2); δH (250 MHz, CDCl3) 1.29–1.39 (6 H, m, 2 × 
CH3), 2.87 (2 H, qd, J 7.1, 5.1, 2 × CH), 7.28–7.81 (20 H, m, ArCH); δP (101 MHz, CDCl3) 
36.7. All data is in accordance with the literature. 
(1R, 1R')-(-)-1,1'-(1,2-Ethanediyl)bis[1-(2-methoxyphenyl)-1-phenyl-phosphine oxide 
14[36] 
(1R, 1R’)-(-)-bis[(2-Methoxyphenyl)phenylphosphino]ethane (100 mg, 0.2 mmol) was 
dissolved in anhydrous CH2Cl2 (5.0 mL) and the solution cooled to 0 °C. Hydrogen peroxide 
(35 wt. %, 0.1 mL) was added dropwise and the solution warmed to room temperature and 
stirred for 12 hours. The reaction was poured into water (3.0 mL) and the organic phase 
separated. The aqueous layer was extracted with CH2Cl2 (3 × 10 mL), and the organic phases 
combined, washed with a saturated aqueous solution of sodium bisulfite (10 mL) and dried 
with MgSO4. Filtration and removal of the solvent in vacuo afforded a white crystalline solid 
as the title compound which required no further purification (100 mg, 96%); m.p. 206 °C; []D25 
-44.5 (c 1.0 in MeOH); δH (400 MHz, CDCl3) 2.57–2.74 (4 H, m, 2 × CH2), 3.57 (6 H, s, 2 × 
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OCH3), 6.79–6.82 (2 H, m, ArCH), 7.08 (2 H, t, J 7.3, ArCH), 7.37–7.49 (8 H, m, ArCH), 
7.72–7.77 (4 H, m, ArCH), 7.97–7.99 (2 H, m, ArCH); δP (121 MHz, CDCl3) 32.2. All data is 
in accordance with that of the literature. 
(S)-2,2'-Bis-(Diphenylphosphinyl)-1,1'-binaphthyl 15[37] 
(S)-2,2'-bis-(Diphenylphosphino)-1,1'-binaphthyl (300 mg, 0.5 mmol) was added to 
dichloromethane (10 cm³) and the solution cooled to 0 °C. Hydrogen peroxide (35 wt.%, 0.2 
cm³) was added dropwise and the mixture stirred for 18 hours. The solution was poured into 
water (10 cm³) and the organic phase separated. The aqueous layer was extracted with diethyl 
ether (3 × 15 cm³) and the combined organic phases washed with a saturated aqueous solution 
of sodium sulfite (10 cm³) and dried over magnesium sulfate. Filtration and removal of the 
solvent in vacuo afforded a white crystalline solid that required no further purification (290 
mg, 95%); m.p. 261 °C (lit.[37] 260.5–261.5 °C); []D25 -390 (c 1.0 in C6H6, lit.[37] -391.2 c 
0.5 in C6H6); δH (250 MHz, CDCl3) 6.78–6.85 (4 H, m, ArCH), 7.26–7.51 (20 H, m, ArCH), 
7.69–7.77 (4 H, m, ArCH), 7.82–7.89 (4 H, m, ArCH); δP (250 MHz, CDCl3) 28.3. All data is 
in accordance with the literature.  
(S)-2,2'-bis(di-o-Tolylphosphinyl)-1,1'-binaphthyl 16 
(S)-(−)-2,2′-bis(di-o-Tolylphosphino)-1,1′-binaphthyl (100 mg, 0.1 mmol) was dissolved in 
dichloromethane (5 cm³) and the solution cooled to 0 °C. Hydrogen peroxide (35 wt. %, 0.2 
cm³) was added dropwise and the reaction mixture stirred for 18 hours. The solution was poured 
into water (10 cm³) and the organic layer separated. The aqueous layer was extracted with 
diethyl ether (3 × 15 cm³) and the combined organic phases washed with a saturated solution 
of sodium sulfite (10 cm³) and dried over magnesium sulfate. Filtration and removal of the 
solvent in vacuo afforded the title compound as a white crystalline solid that required no further 
purification (100 mg, 98%); m.p. 268 °C; []D25 -421 (c 1.0 in C6H6); υmax (ATR)/ cm-1 3658, 
3379, 3046, 2920, 2865, 1601, 1553. 1501; δΗ (400 MHz, CDCl3) 2.33 (12 Η, d, JP-H 23.4, 4 × 
CΗ3), 6.85–6.91 (4 Η, m, ArCΗ), 6.99–7.05 (8 Η, m, ArCΗ), 7.27–7.31 (4 Η, m, ArCΗ), 7.37–
7.55 (8 Η, m, ArCΗ), 7.81–7.86 (4 Η, m, 4 × ArCΗ), 7.82–7.85 (4 Η, m, 4 × ArCΗ); δC (100 
MHz, CDCl3) 21.5 (d, JP-H 2.1, 4 × CH3), 125.9 (ArCH), 127.1 (ArCH), 127.3 (ArCH), 127.4 
(ArCH), 127.7 (ArCH), 128.2 (d, JP-H 13.5, ArCH), 128.5 (2 × ArCH), 128.7 (2 × ArCH), 129.6 
(ArC), 130.4 (d, JP-H 28.4, ArC), 131.4 (ArC), 132.0 (d, JP-H 10.1, ArCH), 132.5 (d, JP-H 12, 
ArCH), 133.7 (d, JP-H 11.4, ArC), 133.9 (d, JP-H 2.5, ArC), 141.1 (d, JP-H 7.9, ArC), 141.2 (d, 
JP-H 7.9, ArC), 142.9 (d, JP-H 6.1, ArC), 143.0 (d, JP-H 6.1, ArC); δP (101 ΜΗz, CDCl3) 28.4; 
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m/z (ESI+) 711.2559 (100%, MH+, C48H41O2P requires 711.2576). 
(R)-1,1'-Binaphthyl-2,2'-diyl bis(trifluoromethanesulfonate) 18[38] 
(R)-BINOL 17 (1.00 g, 4 mmol) was dissolved in a solution of dichloromethane (20 cm³) and 
freshly distilled pyridine (1.0 cm³, 13 mmol) and the mixture cooled to 0 °C. Triflic anhydride 
(3.00 g, 2.0 cm³, 12 mmol) was added dropwise over a period of 30 minutes and the mixture 
warmed to room temperature and stirred for six hours. The solution was diluted with ethyl 
acetate (50 cm³) and the organic phase was separated. The aqueous phase was extracted with 
ethyl acetate (3 × 10 cm³) and the combined organic layers washed sequentially with an 
aqueous solution of 5% HCl (20 cm³), aqueous saturated sodium hydrogen carbonate solution 
(20 cm³) and brine (20 cm³). The organic phase was dried over sodium sulfate, filtered and the 
solvent removed in vacuo to yield an orange oil. Purification of the crude material by column 
chromatography on silica gel using an eluent of 5% ethyl acetate: petroleum ether 40–60 °C 
furnished the title compound as a white crystalline solid (3.03 g, 100%); m.p. 75 °C (lit.[38] 
76–78 °C); []D25 -146.2 (c 1.0 in CHCl3, lit.[38] -147.7 c 1.01 in CHCl3); δH (400 MHz, CDCl3) 
7.27–7.29 (2 H, m, ArCH), 7.41–7.46 (2 H, m, ArCH), 7.59–7.65 (4 H, m, ArCH), 8.03 (2 H, 
d, J 8.0, ArCH), 8.17 (2 H, d, J 9.0, ArCH); δF (235 MHz, CDCl3) -74.57 (2 × CF3). All data 
is in accordance with that of the literature. 
(R)-2-[bis-(o-Tolylphosphinyl)]- 2’-[(trifluoromethanesulfonoyl)oxy]-1,1'-binaphthyl 
19[39] 
(R)-1,1'-Binaphthyl-2,2'-diyl-bis-trifluoromethanesulfonate 18 (0.60 g, 1 mmol) was added to 
a stirred solution of bis-(2-methylphenyl)-phosphine oxide (0.60 g, 3 mmol), palladium acetate 
(0.06 g, 0.3 mmol) and diphenylphosphoryl butane (0.10 g, 0.3 mmol) under an atmosphere of 
argon. N,N-Diisopropylethylamine (0.70 g, 1.0 cm³, 6 mmol) was added dropwise and the 
reaction mixture heated to 120 °C for 12 hours. Upon cooling to room temperature, the solution 
was diluted with ethyl acetate (50 cm³) and washed successively with water (3 × 20 cm³), 1N 
HCl (20 cm³) and an aqueous saturated solution of NaHCO3 (20 cm³). The organic layer was 
dried over magnesium sulfate, filtered, and the solvent removed in vacuo to yield an orange 
oil. Purification of the crude material by flash column chromatography on silica gel using an 
eluent of 40% ethyl acetate: petroleum ether 40–60 °C afforded the title compound as a white 
crystalline solid (630 mg, 74%); m.p. 78 °C (lit.[39] 123–125 °C); []D25 +62.2 (c 0.5 in CHCl3, 
lit.[39] +9.1 (c 0.99, CHCl3); δH (400 MHz, CDCl3) 2.15 (3 H, s, CH3), 2.48 (3 H, s, CH3), 
6.90–7.13 (7 H, m, ArCH), 7.25–7.31 (3 H, m, ArCH), 7.35–7.45 (5 H, m, ArCH), 7.61 (1 H, 
app. t, J 7.1, ArCH), 7.87 (1 H, app. d, J 8.1, ArCH), 7.97–8.01 (3 H, m, ArCH); δF (235 MHz, 
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CDCl3) -75.0; δP (101 MHz, CDCl3) 33.9. Data is in general agreement with the literature. 
(R)-2-[bis-(4-Methoxyphenyl)phosphinyl]-2’-[(trifluoromethanesulfonyl)oxy]-1,1’-
binaphthyl 20[40] 
(R)-1,1'-Binaphthyl-2,2'-diyl-bis-trifluoromethanesulfonate 18 (0.60 g, 1 mmol) was added to 
a stirred solution of bis(4-methoxyphenyl)phosphine oxide (0.60 g, 3 mmol), palladium acetate 
(0.06 g, 0.3 mmol) and 1,4-bis(diphenylphosphino)butane (0.10 g, 0.3 mmol) under an 
atmosphere of argon. N,N-Diisopropylethylamine (0.70 g, 1.0 cm³, 6 mmol) was added 
dropwise and the reaction mixture heated to 120 °C for 12 hours. Upon cooling, the solution 
was diluted with ethyl acetate (50 cm³) and washed successively with water (3 × 20 cm³), 1N 
HCl (20 cm³) and a 1M aqueous solution of NaHCO3 (20 cm³). The organic layer was dried 
over magnesium sulfate, filtered, and the solvent removed in vacuo to yield an orange oil. 
Purification of the crude material by flash column chromatography on silica gel using an eluent 
of 40% ethyl acetate: petroleum ether 40–60 °C afforded the title compound as a white 
crystalline solid (700 mg, 87%); m.p. 81 °C (lit.[40] 80–81 °C); []D25 +66.1 (c 0.7 in CHCl3, 
lit.[40] +66.2 c 0.7 in CHCl3); δH (400 MHz, CDCl3) 3.79 (3 H, s, OCH3), 3.81 (3 H, s, OCH3), 
6.66–6.69 (2 H, m, ArCH), 6.77–6.80 (2 H, m, ArCH), 7.01 (1 H, d, J 8.6, ArCH), 7.12 (1 H, 
d, J 8.6, ArCH), 7.18–7.23 (1 H, m, ArCH), 7.30–7.39 (6 H, m, ArCH), 7.45 (1 H, ddd, J 8.2, 
6.9, 1.2, ArCH), 7.56–7.60 (1 H, m, ArCH), 7.78 (1 H, dd, J 11.4, 8.6, ArCH), 7.84 (1 H, d, J 
8.3, ArCH), 7.90 (1 H, d, J 9.0, ArCH), 7.96 (1 H, d, J 8.3, ArCH), 8.04 (1 H, dd, J 8.8, 2.2, 
ArCH); δF (235 MHz, CDCl3) -75.0; δP (101 MHz, CDCl3) 27.9. All data is in accordance with 
the literature. 
(R)-2’-[bis-(o-Tolylphosphinyl]-[1,1’-binapthalen]-2-ol 21[39] 
(R)-2-[bis-(o-tolylphosphinyl)]- 2’-[(trifluoromethanesulfonoyl)oxy]-1,1'-binaphthyl 19 (0.30 
g, 0.4 mmol) was added to a solution of dioxane (10 cm³) and methanol (5.0 cm³) at room 
temperature. A 3 M solution of NaOH (3.0 cm³) was introduced in a single portion and the 
solution stirred at room temperature for 24 hours. The reaction was acidified to pH 1 using 
concentrated HCl (5.0 cm³) and the aqueous phase extracted with ethyl acetate (3 × 10 cm³). 
The organic phases were combined, washed with brine (10 cm³) and dried over magnesium 
sulfate. Filtration and removal of the solvent in vacuo yielded a yellow oil. Purification of the 
crude material by flash column chromatography on silica gel using an eluent of 50% ethyl 
acetate: petroleum ether 40–60 °C afforded the title compound as a white crystalline solid (210 
mg, 96%); m.p. 162 °C, lit.[39] 150–152 oC; []D25 +135.0 (c 0.7 in CHCl3, lit.[39] -59.8 c 1.11, 
CHCl3); δH (400 MHz, CDCl3) 2.03 (3 H, s, CH3), 2.72 (3 H, s, CH3), 6.21 (1 H, d, J 8.5, 
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ArCH), 6.52–6.63 (2 H, m, ArCH), 6.74–6.81 (2 H, m, ArCH), 7.03–7.25 (6 H, m, ArCH), 
7.47–7.52 (6 H, m, ArCH), 7.70 (1 H, d, J 8.5, ArCH), 7.91–8.00 (2 H, m, ArCH), 9.33 (1 H, 
s, OH); δP (121 MHz, CDCl3) 37.3. All data is in general agreement with the literature. 
(R)-2’-[bis-(4-Methoxyphenyl)phosphinyl]-[1,1’-binapthalen]-2-ol 22[22] 
(R)-2-[bis(4-Methoxyphenyl)phosphinyl]-2’-[(trifluoromethanesulfonyl)oxy]-1,1’-binaphthyl 
20 (0.30 g, 0.4 mmol) was added to a solution of dioxane (10 cm³) and methanol (5.0 cm³) at 
room temperature. A 3 M solution of NaOH (3.0 cm³) was introduced in one portion and the 
solution stirred at room temperature for 24 hours. The reaction was acidified to pH 1 using 
concentrated HCl (5.0 cm³) and the aqueous phase extracted with ethyl acetate (3 × 10 cm³). 
The organic phases were combined, washed with brine (10 cm³) and dried over magnesium 
sulfate. Removal of the solvent in vacuo yielded a yellow oil. Purification of the crude material 
by flash column chromatography on silica gel using an eluent of 50% ethyl acetate: petroleum 
ether 40 60 °C afforded the title compound as a white crystalline solid (215 mg, 100%). m.p. 
178 °C; []D25 -126.0 (c 0.7 in CHCl3, lit.[22] +126.3 c 0.7 in CHCl3 for the (S)-enantiomer); 
δH (400 MHz, CDCl3) 3.55 (3 H, s, OCH3), 3.89 (3 H, s, OCH3), 6.21–6.24 (2 H, m, ArCH), 
6.43 (1 H, app. d, J 8.6, ArCH), 6.92–6.96 (1 H, m, ArCH), 7.05 (2 H, app. dd, J 8.6, 2.3, 
ArCH), 7.10–7.16 (4 H, m, ArCH), 7.20–7.24 (1 H, m, ArCH), 7.38–7.45 (2 H, m, ArCH), 
7.50–7.56 (2 H, m, ArCH), 7.67 (1 H, app. d, J 8.6, ArCH), 7.81–7.92 (4 H, m, ArCH) 9.40 (1 
H, s, OH); δP (121 MHz, CDCl3) 31.3. No melting point data is reported within the literature, 
all other data is in accordance. 
5-Chloro-1-phenyl-pentan-1-one 24[41] 
5-Chlorovaleronitrile 23 (5.00 g, 5.0 cm³, 43 mmol) was added to THF (20 cm³) and the 
solution cooled to 0 °C. Phenyl magnesium bromide (29.0 cm³, 3 M in THF, 86 mmol) was 
added dropwise over a period of 90 minutes and the reaction mixture warmed to room 
temperature and stirred overnight. A 10% aqueous solution of HCl (25 cm³) was added and the 
resulting suspension heated at reflux for 3 hours. The mixture was cooled to room temperature 
and the aqueous phase extracted with dichloromethane (3 × 30 cm³). The organic layers were 
combined, washed with 1M NaOH solution (20 cm³) and dried over magnesium sulfate. 
Filtration and removal of the solvent in vacuo yielded a yellow solid. Recrystallisation of the 
crude material from n-hexane afforded the title compound as a white crystalline material (7.05 
g, 81%); m.p. 50–51 °C (lit.[41] 50 °C); δH (400 MHz, CDCl3) 1.90–1.93 (4 H, m, CH2), 3.03 
(2 H, t, J 6.8, CH2CO), 3.60 (2 H, t, J 6.1, CH2Cl), 7.48 (2 H, t, J 7.5, ArCH), 7.58 (1 H, t, J 




Trimethyl borate (0.1 cm³, 0.5 mmol) was added dropwise to a solution of (1R, 2S)-(+)-1-
amino-2-indanol (0.80 g, 0.5 mmol) in THF (2.0 cm³) at 0 °C and the mixture stirred for 30 
minutes. BH3.DMS (0.50 cm³, 5  mmol) was added dropwise and stirring continued for a further 
45 minutes. The ketone 159 (900 mg, 4 mmol) dissolved in THF (5 cm³) was introduced by 
syringe pump (1.8 cm³ / hr) at 0 °C and the mixture warmed to room temperature and stirred 
for a further 90 minutes following complete addition of the ketone 24. Methanol (5.0 cm³) was 
added in a single portion and the aqueous phase extracted with dichloromethane (3 × 15 cm³). 
The organic layers were combined, washed with 1M HCl (10 cm³), brine (10 cm³) and dried 
over magnesium sulfate. Filtration and removal of the solvent in vacuo yielded a yellow oil. 
Purification of the crude material by flash column chromatography on silica gel using an eluent 
of 3% ethyl acetate: petroleum ether 40–60 °C afforded the title compound as a white fluffy 
solid (800 mg, 83%). A racemic version of the alcohol rac-25 was prepared through treatment 
of the ketone 24 with sodium borohydride. m.p. 37 °C; []D25 -17.4 (c 1.0 in C6H6, lit.[41] -
14.16 c 1.90, C6H6, 94% ee for (S)-enantiomer); δH (400 MHz, CDCl3) 1.40–1.51 (1 H, m, 
CHH), 1.51–1.57 (1 H, m, CHH), 1.70–1.87 (5 H, m, 2 × CH2 and OH), 3.54 (2 H, t, J 6.8, 
CH2Cl), 4.70 (1 H, t, J 6.8, CHOH), 7.28–7.41 (5 H, m, ArCH); δC (100 MHz, CDCl3) 23.3 
(CH2), 32.5 (CH2), 38.2 (CH2), 44.9 (CH2Cl), 74.4 (CHOH), 125.9 (2 × ArCH), 127.7 (ArCH), 
128.6 (2 × ArCH), 144.6 (ArC). No melting point or 13C NMR data is reported within the 
literature for this enantiomer, otherwise all other data is in accordance. The enantioselectivity 
of this compound could not be assayed at this stage. 
(S)-tert-Butyl(5-chloro-1-phenylpentyloxy)dimethylsilane 26 
(S)-5-Chloro-1-phenyl-pentan-1-ol 25 (1.00 g, 5 mmol) was added to a solution of 4-
diaminomethylpyridine (0.20 g, 2 mmol) and triethylamine (2.00 g, 2.0 cm³, 15 mmol) in 
dichloromethane (20 cm³). The solution was cooled to 0 °C and tert-
butyl(chloro)dimethylsilane (2.00 g, 10 mmol) added in a single portion. The reaction mixture 
was stirred for 18 hours before being poured into water (10 cm³). The organic phase was 
separated and aqueous layer extracted with diethyl ether (3 × 15 cm³). The organic layers were 
combined, washed with 1M NaOH (10 cm³), brine (10 cm³) and dried over magnesium sulfate. 
Filtration and removal of the solvent in vacuo yielded a yellow oil. Purification of the crude 
material by flash column chromatography on silica gel using an eluent of 10% ethyl acetate: 
petroleum ether 40–60 °C afforded the title compound as a colourless oil (936 mg, 60%). A 
racemic version of the molecule rac-26 was prepared in analogous fashion from the racemic 
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alcohol 25; []D25 -33.0 (c 0.5 in CHCl3); υmax (ATR)/ cm-1 3121, 3061, 1515; δH (400 MHz, 
CDCl3) -0.12 (3 H, s, SiCH3), 0.05 (3 H, s, SiCH3), 0.91 [9 H, s, (CH3)3], 1.37–1.55 [6 H, m, 
(CH2)3], 3.52 (2 H, t, J 6.9, CH2Cl), 4.66 (1 H, dd, J 7.5 4.8, CH), 7.22–7.34 (5 H, m, ArCH); 
δC (100 MHz, CDCl3) -5.0 (SiCH3), -4.6 (SiCH3), 18.3 (C[CH3]3), 23.0 (CH2), 25.7 (3 × CH3), 
32.6 (CH2), 40.1 (CH2), 44.9 (CH2), 74.8 (CH), 125.8 (2 × ArCH), 126.9 (2 × ArCH), 128.0 
(ArCH), 145.5 (ArC); m/z (TOF) 317.1751 (100%, MH+, C17H29
35ClOSi requires 313.1754).  
(S)-5-(Diphenylphosphinyl)-1-phenylpentan-1-ol 27 
(S)-tert-Butyl(5-chloro-1-phenylpentyloxy)dimethylsilane 26 (0.10 g, 0.4 mmol) was added to 
a stirred suspension of triphenylphosphine (0.10 g, 0.4 mmol) and sodium iodide (0.06 g, 0.4 
mmol) in acetonitrile (5.0 cm³) and the solution heated to reflux for 18 hours. The solvent was 
removed in vacuo to afford the crude phosphonium salt that was immediately dissolved in a 
30% NaOH solution (10 cm³) and heated to reflux for a further 24 hours. The aqueous phase 
was extracted with dichloromethane (3 × 10 cm³), washed with an aqueous solution of NaHCO3 
(10 cm³) and dried over magnesium sulfate. Removal of the solvent in vacuo yielded a yellow 
oil. The crude material was dissolved in THF (10 cm³) and cooled to 0 °C. TBAF (1.5 cm³, 1M 
in THF, 0.8 mmol) was added dropwise and the solution warmed to room temperature and 
stirred for 24 hours. The reaction mixture was poured into water (5.0 cm³) and ethyl acetate 
(10 cm³) and the organic layer separated. The aqueous phase was extracted with ethyl acetate 
(3 × 10 cm³) and the organic layers combined, washed with 1M NaOH (10 cm³), brine (10 cm³) 
and dried over magnesium sulfate. Filtration and removal of the solvent in vacuo yielded a 
yellow oil. Purification of the crude material by flash column chromatography on silica gel 
using an eluent of 50% ethyl acetate: petroleum ether 40–60 °C afforded the title compound as 
a colourless oil (45 mg, 33%). A racemic version of the catalyst rac-27 was prepared in 
analogous fashion from the TBS ether rac-26; tR 10.5 min (S isomer) and 13.2 min (R isomer) 
(Celluose-1, 1: 1 hexane: propan-2-ol); []D25 -4.0 (91% ee from HPLC, c 0.2 in CHCl3); υmax 
(ATR) / cm-1 3430, 1641, 1515; δH (400 MHz, CDCl3) 1.41–1.85 (5 H, m, CH2), 2.18–2.30 (3 
H, m, CH2), 4.64–4.67 (1 H, m, CHOH), 7.26–7.36 (4 H, m, ArCH), 7.46–7.56 (6 H, m, ArCH), 
7.71–7.75 (4 H, m, ArCH); δC (100 MHz, CDCl3) 21.3 (d, JC-P 4.0, CH2), 27.0 (d, JC-P 14.0, 
CH2), 29.5 (d, JC-P 71.0, CH2), 38.6 (CH2P), 73.7 (CHOH), 125.9 (2 × ArCH), 127.1 (ArCH), 
128.2 (2 × ArCH), 128.5 (2 × ArCH), 128.7 (2 × ArCH), 130.6 (d, JC-P 4.0, 2 × ArCH), 130.7 
(d, JC-P 4.0, 2 × ArCH),  131.65 (ArCH), 131.68 (ArCH), 132.3 (d, JC-P 8.4, ArC), 133.4 (d, JC-
P 8.4, ArC), 145.2 (ArC); δP (121 MHz, CDCl3) 32.4; m/z (TOF ES+) 365.1671 (100%, MH+, 





Methyl diphenylphosphine oxide[42] 28 (0.50 g, 2 mmol) was dissolved in anhydrous THF (10 
cm³) and the solution cooled to 0 °C. n-Butyl lithium (2.0 cm³, 2M in hexanes, 4 mmol) was 
added dropwise and the reaction mixture stirred for 90 minutes. (S)-2-Phenyloxirane (0.3 cm³, 
2.5 mmol) was introduced and the solution warmed to room temperature and stirred overnight. 
The mixture was poured into a saturated ammonium chloride solution (10 cm³) and the aqueous 
phase extracted with diethyl ether (3 × 15 cm³). The organic layers were combined, washed 
with brine (15 cm³) and dried over magnesium sulfate. Removal of the solvent in vacuo 
afforded a yellow oil. Purification of the crude material by flash column chromatography on 
silica gel using an eluent of 10% methanol: ethyl acetate afforded the title compound as a white 
solid (604 mg, 78%). m.p. 127 °C (lit.[33] 144–145 °C for racemate); []D25 -11.5 (c 0.7 in 
CHCl3); δH (CDCl3, 400 MHz) 1.99–2.20 (2 H, m, CH2), 2.33–2.50 (2 H, m, CH2), 2.65 (1 H, 
br s, OH), 4.86 (1 H, dd, J 7.3, 4.2, CH), 7.25–7.35 (5 H, m, ArCH), 7.46–7.57 (6 H, m, ArCH), 
7.70–7.77 (4 H, m, ArCH); δP (CDCl3, 101 MHz) 32.7. No data is reported on the 
enantiomerically pure compound. 
(SP)-Phenyl-(2-anisyl)-but-3-ene phosphine oxide 31[42] 
N-Phosphinyl oxazolidinone[26] 30 (120 mg, 0.3 mmol) was dissolved in THF (2.0 mL) and 
added by syringe pump (1.0 mL / hr) to a solution of but-3-enylmagnesium bromide (4 mL, 1 
M in THF, 4 mmol) and THF (4.0 mL). Once addition was complete the reaction mixture was 
quenched through addition of a saturated aqueous solution of ammonium chloride (5.0 mL) 
and the aqueous phase extracted with CH2Cl2 (3 × 10 mL). The organic layers were combined, 
washed with brine (10 mL) and dried over MgSO4. Filtration and removal of the solvent in 
vacuo yielded a crude yellow oil. Purification of the crude material by flash column 
chromatography on silica gel using a gradient eluent of 75% EtOAc: petroleum ether 40–60 °C 
to 5% MeOH: CH2Cl2 afforded the oxazolidinone (44 mg, 91%) as a white solid and the 
phosphine oxide 31 as a colourless oil (63 mg, 77%); tR 10.5 (minor isomer) and 18.8 (major 
isomer) (Celluose-1, 90: 10 hexane: propan-2-ol, 210 nm); []D25 +23.0 (c 1.0 in CHCl3); υmax 
/ cm-1 (ATR) 3076, 2976, 1640, 1590; δH (400 MHz, CDCl3) 2.22–2.60 (4 H, m, 2 × CH2), 3.76 
(3 H, s, OCH3), 4.93–5.04 (2 H, m, CH=CHH), 5.84 (1 H, ddt, J 16.8, 10.2, 6.4, CH=CHH), 
6.88 (1 H, dd, J 8.3 5.4, ArCH), 7.08–7.12 (1 H, m, ArCH), 7.39–7.52 (4 H, m, ArCH), 7.75–
7.81 (2 H, m, ArCH), 7.97–8.03 (1 H, m, ArCH); δC (101 MHz, CDCl3) 25.7 (d, JC-P 3.0, CH2), 
28.5 (d, JC-P 73.0, CH2), 55.3 (OCH3), 110.8 (d, JC-P 6.6, ArCH), 114.8 (CH=CHH), 119.3 (d, 
JC-P 95.7, ArC), 121.2 (d, JC-P 10.6, ArCH), 128.2 (d, JC-P 11.8, 2 × ArCH), 130.6 (d, JC-P 9.7, 
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2 × ArCH), 131.3 (d, JC-P 2.4, ArCH), 133.5 (ArC), 133.9 (CH=CHH), 134.5 (d, JC-P 5.2, 
ArCH), 137.8 (d, JC-P 16.3, ArCH), 159.7 (d, JC-P 5.0, ArC); δP (101 MHz, CDCl3) 31.4; m/z 
(TOF ES+) 287.1195 (100%, MH+, C17H20O2P requires 287.1201). No data is reported in the 
literature. 
1,6-bis[(SP)-(2-Methoxyphenyl)(phenyl)phosphinyl]hexane 32 
Phosphine oxide 31 (90 mg, 0.3 mmol) was added to a solution of CH2Cl2 (3 mL) and Hoveyda-
Grubbs II catalyst (18 mg, 0.03 mmol) and the solution heated at reflux for 18 h. Upon cooling 
to room temperature, the volatiles were removed in vacuo and the residue purified by flash 
column chromatography on silica gel using a gradient eluent of 100% EtOAc to 5% MeOH: 
CH2Cl2 to afford a yellow oil. The oil (54 mg, 0.1 mmol) was dissolved in MeOH (2 mL) and 
subjected to a single cycle through a Pd/C Thalesnano Catcart H-CubeTM under 1 atmosphere 
of hydrogen at 30 °C. Removal of the solvent in vacuo afforded the title compound as a 
colourless oil (50 mg, 61% over 2 steps); []D25 +42.0 (c 1.0 in CHCl3); υmax / cm-1 (ATR) 3062, 
2929, 1588, 1575; δH (400 MHz, CDCl3) 1.30–1.65 (8 H, m, 4 × CH2), 2.22–2.47 (4 H, m, 2 × 
CH2), 3.72 (6 H, s, 2 × OCH3), 6.82–6.90 (2 H, m, ArCH), 7.07–7.10 (2 H, m, ArCH), 7.40–
7.50 (8 H, m, ArCH), 7.72–7.77 (4 H, m, ArCH), 7.95–8.00 (2 H, m, ArCH); δC (101 MHz, 
CDCl3) 21.4 (d, JC-P 3.0, CH2), 28.7 (CH2), 29.4 (CH2), 30.5 (d, JC-P 3.0, CH2), 55.3 (2 × OCH3), 
110.7 (d, JC-P 6.6, 2 × ArCH), 120.5 (d, JC-P 95.9, 2 × ArC), 121.1 (d, JC-P 10.6, 2 × ArCH), 
128.1 (d, JC-P 11.7, 4 × ArCH), 130.5 (d, JC-P 9.6, 4 × ArCH), 131.2 (2 × ArCH), 133.8 (2 × 
ArCH), 134.1 (d, JC-P 75.3, 2 × ArC), 134.5 (d, JC-P 5.2, ArCH), 159.7 (d, JC-P 5.0, 2 × ArC); 
δP (101 MHz, CDCl3) 32.0; m/z (TOF ES+) 547.2190 (100%, MH+, C32H37O4P2 requires 
547.2167). 
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